[1] |
LENG Jie, QIU Guochun, ZHANG Bo, PU Yan.
Mechanism of breast cancer centrosome regulatory protein SEC23B on tumor invasion and metastasis
[J]. China Oncology, 2023, 33(2): 152-161.
|
[2] |
YU Hang, LIU Wensheng, ZHANG Ning, LIU Haikuan, CHEN Luohai, YAO Wang, FAN Wenzhe, LI Jiaping, CHEN Jie, WANG Yu.
The efficacy and safety analysis of transarterial embolization in the treatment of cystic neuroendocrine neoplasm liver metastasis
[J]. China Oncology, 2022, 32(9): 794-799.
|
[3] |
ZHENG Xiuli, YAO Zhiyuan, WU Mingli, ER Limian, LI Shengmian.
Analysis of risk factors of lymph node metastasis and comparison of endoscopic resection methods in rectal neuroendocrine neoplasm
[J]. China Oncology, 2022, 32(9): 800-806.
|
[4] |
HONG Yaping, HUANG Yunjian, HUANG Zhangzhou, CHEN Shengjia, ZHONG Qiaofeng, ZENG Hongfu, ZHUANG Wu.
Efficacy and prognostic predictors of first-generation EGFR TKI-targeted therapy in patients with EGFR-mutated advanced non-small cell lung cancer
[J]. China Oncology, 2022, 32(7): 624-634.
|
[5] |
QU Yiping, HOU Peng.
Genetic characteristics and prognosis of metastatic thyroid cancer in children
[J]. China Oncology, 2022, 32(5): 373-379.
|
[6] |
DENG Shuting, FENG Yuan, QIAN Kai, GUO Kai, WANG Zhuoying.
Meta-analysis of the association between gene alterations and distant metastasis of differentiated thyroid carcinoma in children and adolescents
[J]. China Oncology, 2022, 32(5): 388-396.
|
[7] |
FU Yuanyuan, HOU Runping, FU Xiaolong.
Research progress in predicting the risk of lymphatic or hematologic metastasis based on chest CT in early non-small cell lung cancer
[J]. China Oncology, 2022, 32(4): 343-350.
|
[8] |
MU Jiaqian, TENG Xiaoyan, WEI Lirong, QIU Rong, GUI Pengcheng, DU Yuzhen.
The role and application value of integrin β3 in bone metastasis of lung adenocarcinoma
[J]. China Oncology, 2022, 32(4): 351-356.
|
[9] |
ZHOU Changshuai, YANG Yuechao, CUI Huanhuan, CHEN Lei, CHEN Xin, HAO Bin, TONG Tong, CAO Yiqun.
Prognostic factor analysis of surgical treatment for cerebellar metastases in 36 patients
[J]. China Oncology, 2022, 32(4): 357-362.
|
[10] |
The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River.
Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
[J]. China Oncology, 2022, 32(3): 274-286.
|
[11] |
WANG Jiahui, JIANG Linlan, SHEN Zan.
New progress and prospect of breast cancer bone metastasis research from mechanism to clinic
[J]. China Oncology, 2022, 32(2): 172-176.
|
[12] |
HAN Ruxue, LIANG Xiang, MA Xuhui, GUO Wei, WU Yunteng, REN Guoxin.
Characteristics and prognostic analysis of oral mucosal melanoma with lung metastasis
[J]. China Oncology, 2022, 32(12): 1184-1189.
|
[13] |
MEI Xiaoran, FENG Fang, WANG Hui, WEI Zhixiao.
Analysis of therapeutic response of iodine positive metastasis lymph nodes in differentiated thyroid cancer after 131I treatment
[J]. China Oncology, 2022, 32(11): 1091-1097.
|
[14] |
LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin.
The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer
[J]. China Oncology, 2021, 31(9): 838-844.
|
[15] |
GONG Chao , CHEN Kui , ZHANG Dekun , XIE Jingfeng , WU Fanghua , HUANG Yudian , XUE Yuqin , WANG Liqun .
Construction of a prediction model for metastasis in gastric cancer based on the weighted gene co-expression network analysis
[J]. China Oncology, 2021, 31(8): 746-753.
|